临床肝胆病杂志Issue(1)：62-67,6.DOI:10.3969/j.issn.1001-5256.2016.01.009
肝细胞癌治疗后的影像学评价标准及应用
Radiological evaluation after treatment of hepatocellular carcinoma:criteria and application
王文军 1赵艳 1韩国宏1
作者信息
- 1. 第四军医大学西京消化病医院 消化介入科，西安710032
- 折叠
摘要
Abstract
An early and accurate response evaluation is essential for clinicians to decide whether to continue the treatment with current thera-peutic regimen or to make necessary changes.This article briefly introduces the development of response evaluation criteria for tumors,elab-orates on the application of radiological evaluation criteria in local interventional therapy or sorafenib treatment of hepatocellular carcinoma (HCC),compares the four radiological evaluation criteria,i.e.,World Health Organization (WHO)criteria,Response Evaluation Criteria in Solid Tumors (RECIST),European Association for the Study of Liver (EASL)criteria,and the modified RECIST (mRECIST),and thinks that EASL criteria and mRECIST are better than WHO criteria and RECIST and can predict the prognosis of HCC patients at earlier time points.关键词
癌,肝细胞/疗效评价/诊断显像Key words
carcinoma,hepatocellular/response evaluation/diagnostic imaging分类
医药卫生引用本文复制引用
王文军,赵艳,韩国宏..肝细胞癌治疗后的影像学评价标准及应用[J].临床肝胆病杂志,2016,(1):62-67,6.
